 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine for Sale > Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent buy - large image1

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent buy - image1

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent buy - image2

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent buy - image3

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent buy - image4

Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent

Name: Factory Supply Erdafitinib White Powder CAS 1346242-81-6 Lab Biochemical Research Reagent
Brand: jianxin
SKU: pr2607132653
Price: 1 USD
Availability: InStock

112 Inquiries

Unit Price:

$1-1.3/MT FOB

Get Latest Price 

CAS No.:

1346242-81-6

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Brand:

jianxin

Packaging:

Dideu

Price valid (until):

2030-01-01

Contact Supplier

 Chat Now

Shanghai Jianqi Chemical Company

Company Type:

Trader

Location:

China

Qualification:

Main Products:

chemical raw materials

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Erdafitinib, CAS number 1346242-81-6, is an organic small-molecule pharmaceutical intermediate with high purity up to 99% HPLC. It is synthesized through multi-step organic synthesis and recrystallization purification process, provided as uniform white fine powder for laboratory biochemical research and preclinical new drug development only.

This compound is a classic FGFR targeting small molecule reagent widely used in university laboratories, biotech research institutes and pharmaceutical R&D companies. Our production strictly controls synthesis by-products, residual solvents and heavy metal content. Each batch undergoes complete HPLC purity detection, mass spectrum identification, moisture and ash testing, and can provide full set of supporting documents including COA, MSDS, TDS and chromatogram reports for customs clearance and experimental verification.

The powder owns stable chemical properties under dry, sealed and light-proof storage conditions. It dissolves rapidly in DMSO for cell culture preparation and in organic solvents for synthetic route optimization experiments. This product is exclusively for scientific research, cell model experiments, compound structural activity relationship study and new drug screening; it is not finished medicine and cannot be directly used for clinical treatment or human medication.

We offer diversified neutral unbranded packaging options including small trial foil bags, 1kg vacuum aluminum bags and 25kg industrial cardboard drums. Custom neutral labels and stable bulk supply are supported to meet sample testing and mass research raw material demand for global research institutions and pharmaceutical manufacturers.

Product Advantages

High purity ≥99% HPLC, low single impurity and total impurities, stable chemical composition to ensure repeatable experimental data.
Uniform white fine powder without caking, good dispersion in organic solvents for cell administration and synthetic reaction preparation.
Complete full-batch inspection system, each batch equipped with HPLC and MS identification data, all official certification documents available.
Stable molecular structure, not easy to degrade under dry dark storage, long service life within validity period.
Clear solubility characteristics, compatible with common organic experimental solvents, suitable for in vitro cell culture and synthetic route exploration.
Zero-logo neutral packaging, multiple specifications from lab trial samples to industrial bulk packages, flexible customization service.
Direct factory supply with stable output, professional export document support and after-sales technical consultation for pharmaceutical research customers.

Items	Specifications
Product Name	Erdafitinib
CAS No.	1346242-81-6
Purity	≥99% HPLC

FGFR target molecular mechanism research

Erdafitinib is standard small molecule research reagent for fibroblast growth factor receptor related signaling pathway experiments. It is applied in cell and tissue models to study FGFR protein binding characteristics, downstream kinase signal transmission and cell proliferation regulation mechanism, laying raw material foundation for tumor molecular biology basic research.
Preclinical new drug screening experiment

Pharmaceutical R&D teams adopt this high-purity powder to carry out compound intervention tests, optimize drug action concentration, observe cell growth state changes under target inhibition, and screen potential targeted small molecule candidate compounds.
Compound structure-activity relationship research

Researchers modify the parent skeleton of Erdafitinib to synthesize analog derivatives, compare target binding activity differences of different structures, and explore the correlation between molecular structure and target inhibitory activity.
Drug formulation stability test

Used for compatibility experiments with other pharmaceutical intermediates and auxiliary materials, study storage stability, solvent matching and dosage form preparation feasibility of targeted small molecule compounds.
Pharmacy laboratory teaching & academic research

Common experimental reagent for pharmaceutical major cell biology courses, used for small molecule compound dissolution training, target protein inhibition comparison experiments and drug screening simulation tests.

Basic Info

Product Name:

N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine

Other Name:

1,2-Ethanediamine,N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;Erdafitinib;JNJ 42756493;Balversa;1620332-47-9

CAS No.:

1346242-81-6

Molecular Formula:

C25H30N6O2

InChIKeys:

InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N

Molecular Weight:

446.54

Exact Mass:

446.54

UNII:

890E37NHMV

NCI Thesaurus Code:

C103273

ATC Code:

L - Antineoplastic and immunomodulating agents

Categories:

Bulk Drug Intermediates

Characteristics

PSA:

77.3

XLogP3:

3.2

Density:

1.2±0.1 g/cm3

Flash Point:

354.4±31.5 °C

Refractive Index:

1.618

Water Solubility:

<1 mg/mL

See More N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine Properties 

Hazard Identification

Classification of the substance or mixture

Acute toxicity - Category 4, Oral

Skin sensitization, Sub-category 1B

Serious eye damage, Category 1

Reproductive toxicity, Category 2

Specific target organ toxicity â repeated exposure, Category 1

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Danger
Hazard statement(s)	H302 Harmful if swallowed H317 May cause an allergic skin reaction H318 Causes serious eye damage H361 Suspected of damaging fertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure
Prevention	P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/... P203 Obtain, read and follow all safety instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response	P301+P317 IF SWALLOWED: Get medical help. P330 Rinse mouth. P302+P352 IF ON SKIN: Wash with plenty of water/... P333+P317 If skin irritation or rash occurs: Get medical help. P321 Specific treatment (see ... on this label). P362+P364 Take off contaminated clothing and wash it before reuse. P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P317 Get medical help. P318 IF exposed or concerned, get medical advice. P319 Get medical help if you feel unwell.
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
chemical raw materials

Location:
Building 1, Unit 5, Room 313, Building L, No. 688 Qiushi Road, Jinshuiwei Town, Jinshan District, Shanghai

Average lead Time:
10

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2019

Inquiry History

112 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Hot Selling ERDAFITINIB 1346242-81-6 Factory Supply Raw Materials High Qulity Wholesale price	3 MT	Jul 5, 2026
Bulgaria	Erdafitinib	500 MG	Jun 18, 2026
Switzerland	1g Erdafitinib raw powder >99% purity	1 G	May 22, 2026
Norway	Erdafitinib	1 G	Jul 14, 2026
Thailand	High Quality Erdafitinib 99% powder 1346242-81 fulecare	1 G	Jul 14, 2026
Ireland	Erdafitinib	1 G	Jul 14, 2026
United States	Erdafitinib	1 G	Jul 13, 2026
Finland	erdafitinib	1 G	Jul 12, 2026
Philippines	Erdafitinib	1 G	Jul 12, 2026
Canada	Erdafitinib powder	1 G	Jul 12, 2026
Germany	Erdafitinhib	500 MG	Jul 12, 2026
Switzerland	Erdafitinib	20 MG	Jul 9, 2026
Canada	Erdafitinib Raw Powder	10 KG	Jul 9, 2026
Indonesia	Erdafitinib	5 G	Jul 9, 2026
Romania	Erdafitinib	1 G	Jul 6, 2026
Germany	Erdafitinib	1 G	Jul 6, 2026
Netherlands	Erdafitinib	1 G	Jul 5, 2026
Ireland	Erdafitinib	1 G	Jul 4, 2026
Netherlands	Erdafitinib	1 G	Jul 3, 2026
United States	Erdafitinib	1 G	Jul 1, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
ERDAFITINIB high quality	/	$1-1.3/BOU FOB	Nanjing Paron Technology Co., Ltd	Inquiry
N1-(3,5-Dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine 99%	/	$147-150/G FOB	Conier Chem&Pharma Limited	Inquiry
Erdafitinib CAS 1346242-81-6 JNJ-42756493 Balversa FGFR Tyrosine Kinase Inhibitor Anti-Cancer API 99% Purity	Pharmaceutical Grade/99	$5-6/MT FOB	Hangzhou Hyper Chemicals Limited	Inquiry
ERDAFITINIB 98% yellow powder 1346242-81-6 Senwayer	Pharmaceutical Grade/98		Dingwang Technology (Wuhan) Co., Ltd.	Inquiry
Erdafitinib	/99.00		HANGZHOU LEAP CHEM CO., LTD.	Inquiry